CAS 21028-20-6
:méthosulfate de 3-méthylcytidine
Cytidine, 3-methyl-, mono(methyl sulfate) (salt) (8CI,9CI)
CAS :Formule :C11H19N3O9SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :369.34833-Methylcytidine methosulfate
CAS :3-Methylcytidine (methosulfate), a derivative of cytidine, serves as an internal standard for HPLC and is recognized for its epigenetic modification in tRNA, although its cellular role remains unclear. Research has explored its utility as a cancer biomarker, with findings indicating a notable increase in the urine of breast cancer patients.Formule :C11H19N3O8SCouleur et forme :SolidMasse moléculaire :353.353-Methyl Cytidine Methosulfate
CAS :Produit contrôléApplications Cytidine derivative.
References Ueda, T., et al.: Chem. Pharmaceut. Bull., 22, 2377 (1974),Formule :C10H16N3O5·CH3O4SCouleur et forme :NeatMasse moléculaire :369.353-Methyl Cytidine-d3 Methosulfate-d3
CAS :Produit contrôléApplications Labelled Cytidine derivative.
References Ueda, T., et al.: Chem. Pharmaceut. Bull., 22, 2377 (1974),Formule :C10D3H12N3O5·CD3HO4SCouleur et forme :NeatMasse moléculaire :375.385N3-Methylcytidine methosulfate
CAS :N3-Methylcytidine methosulfate is a novel antiviral agent that inhibits the synthesis of DNA and RNA. It has been shown to be effective against hepatitis B virus, herpes simplex virus, varicella-zoster virus, human immunodeficiency virus, and cytomegalovirus. N3-Methylcytidine methosulfate was found to be active in a variety of animal models including mice and rats. This drug has anticancer properties in the treatment of leukemia, lymphoma, and breast cancer. The phosphoramidite derivative of N3-methylcytidine methosulfate is used as an activator for oligonucleotide synthesis.
Formule :C10H15N3O5·CH4SO4Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :369.35 g/mol




